Metronidazol Avmc

Metronidazole, the active ingredient in Metronidazol Avmc, is a nitroimidazole presented as an oral tablet for systemic use. It treats anaerobic bacterial and protozoal infections in adults and children as prescribed. GNH USA supplies Metronidazol Avmc as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metronidazole is used to manage infections caused by anaerobic bacteria and certain protozoa. - Bacterial vaginosis: restores normal vaginal flora by eliminating anaerobic pathogens. - Trichomoniasis: eradicates Trichomonas vaginalis, relieving symptoms and preventing transmission. - Amoebic dysentery: clears Entamoeba histolytica from the intestinal tract, reducing diarrhea and abdominal pain. - Anaerobic bacterial infections: controls mixed‑flora infections such as intra‑abdominal or pelvic abscesses.

Metronidazole may cause a range of adverse reactions.

Common Side Effects: - Nausea: mild to moderate upset stomach. - Metallic taste: persistent metallic sensation in the mouth. - Headache: transient cranial discomfort. - Diarrhea: loose stools during therapy.

Serious or Rare Side Effects: - Seizures: convulsive episodes requiring immediate medical attention. - Peripheral neuropathy: tingling or numbness in extremities. - Severe allergic reactions: rash, swelling, or anaphylaxis.

Metronidazole requires careful use in several clinical situations. - Liver function assessment: evaluate hepatic status before initiating therapy. - Neurological monitoring: watch for signs of peripheral neuropathy or seizures. - Alcohol avoidance: advise patients to abstain from alcohol during and 48 hours after treatment. - Pregnancy considerations: use only if benefits outweigh potential risks, as safety data are limited. - Renal dose adjustment: modify dosing in patients with severe renal impairment. - Store at below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Metronidazole can interact with several medicines, altering efficacy or safety.

Major Interactions (Avoid): - Alcohol: may cause a disulfiram‑like reaction with flushing and vomiting. - Warfarin: potentiates anticoagulant effect, increasing bleeding risk. - Lithium: can raise lithium serum levels, leading to toxicity.

Moderate Interactions (Monitor Closely): - Phenytoin: may reduce metronidazole concentrations, decreasing effectiveness. - Cimetidine: can increase metronidazole levels, heightening side‑effect potential. - Oral contraceptives: may reduce hormonal efficacy, requiring additional contraceptive measures.